GTx024
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GTx024, covering 2024-03-08 to 2024-03-08. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Study of GTx024 in Women With Metastatic Breast Cancer [Phase 2]